plasminogen信息详情
n.[生化]血纤维蛋白溶酶原
plasminogen drug───纤溶酶原药物
plasminogen def───纤溶酶原def
plasminogen plg───纤溶酶原plg
plasminogen sc───纤溶酶原sc
plasminogen act───纤溶酶原作用
plasminogen ec───纤溶酶原ec
plasminogen mw───纤溶酶原分子量
tissue plasminogen activator───[医]组织纤维蛋白溶酶原激活剂;组织纤溶酶原激活物
Urokinase, a human plasminogen activator, is used clinically to promote the dissolution of thrombi.───尿激酶是一种纤溶酶原激活剂,临床上用于治疗血栓。
We measured the plasminogen (PLG) content and plasmin (pl) activity in 54 leukemic patients.───对54例白血病患者进行血浆纤溶酶原(plg)及纤溶酶(PL)活性测定。
We studied the mechanism of plasma and tissue kallikrein in activating plasminogen.───作者研究了血浆和组织激肽释放酶激活纤溶酶原的机制。
Conclusion The diabetic nephropathy patients have imbalance of plasma plasminogen activator and its inhibitor system.───结论:糖尿病肾病患者存在血浆纤溶酶原激活物及其抑制物系统失衡。
abstract: Objective To investigate the plasminogen activator inhibitor changes in patients with diabetic nephropathy.───目的:探讨糖尿病肾病患者血浆纤溶酶原激活物抑制物的变化。
Recombinant tissue-type plasminogen activator (r-TPA) was also used when clinically indicated.───临床上有指征时也可应用重组组织型纤溶酶原激活剂。
Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review.───急性缺血性卒中患应用重组组织纤溶酶原激活剂治疗的效用成本:一项系统性回顾
The abnormal activity of tissue-type plasminogen activator(t-PA) is the most risk factor of prethrombotic state of cardiovascular diseases.───组织型纤溶酶原激活物(tPA)活性异常是心血管疾病血栓前状态的最危险因素。
Plasminogen has been immobilized onto a segmented polyurethane containing amino groups, using glutaraldehyde as coupling agent.───纤溶酶原已被固定在一个分割的含氨基酸组,用偶联剂戊二醛聚氨酯。
- product review
- quality innovation award
- peripheral interface circuit
- panel diagram
- plasmochin
- make effort to sth
- self loading cargo
- self loading vehicle
- not disturbing
- make effort todo
- shipping tag
- research description
- popular space
- maximum pore diameter
- roofscape
- make efforts to
- rooflris
- microdontic
- really love it
- never make a decision
- product review in english